Amgen Statistics

Total Valuation

Amgen has a market cap or net worth of EUR 134.14 billion. The enterprise value is 175.49 billion.

Market Cap	134.14B
Enterprise Value	175.49B

Important Dates

The last earnings date was Monday, August 4, 2025.

Earnings Date	Aug 4, 2025
Ex-Dividend Date	May 16, 2025

Share Statistics

Current Share Class	538.36M
Shares Outstanding	n/a
Shares Change (YoY)	+0.19%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	536.98M

Valuation Ratios

The trailing PE ratio is 23.80 and the forward PE ratio is 14.21.

PE Ratio	23.80
Forward PE	14.21
PS Ratio	4.51
PB Ratio	21.21
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 12.51, with an EV/FCF ratio of 19.43.

EV / Earnings	31.14
EV / Sales	5.86
EV / EBITDA	12.51
EV / EBIT	19.04
EV / FCF	19.43

Financial Position

The company has a current ratio of 1.31, with a Debt / Equity ratio of 7.57.

Current Ratio	1.31
Quick Ratio	0.82
Debt / Equity	7.57
Debt / EBITDA	3.44
Debt / FCF	5.30
Interest Coverage	3.11

Financial Efficiency

Return on equity (ROE) is 99.14% and return on invested capital (ROIC) is 10.15%.

Return on Equity (ROE)	99.14%
Return on Assets (ROA)	7.51%
Return on Invested Capital (ROIC)	10.15%
Return on Capital Employed (ROCE)	15.93%
Revenue Per Employee	1.06M
Profits Per Employee	201,289
Employee Count	28,000
Asset Turnover	0.39
Inventory Turnover	1.47

Taxes

In the past 12 months, Amgen has paid 685.46 million in taxes.

Income Tax	685.46M
Effective Tax Rate	10.84%

Stock Price Statistics

The stock price has decreased by -14.34% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	-14.34%
50-Day Moving Average	252.39
200-Day Moving Average	264.33
Relative Strength Index (RSI)	48.84
Average Volume (20 Days)	257

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	5.08

Income Statement

In the last 12 months, Amgen had revenue of EUR 29.73 billion and earned 5.64 billion in profits. Earnings per share was 10.41.

Revenue	29.73B
Gross Profit	20.62B
Operating Income	9.14B
Pretax Income	6.32B
Net Income	5.64B
EBITDA	13.75B
EBIT	9.14B
Earnings Per Share (EPS)	10.41

Full Income Statement

Balance Sheet

The company has 6.84 billion in cash and 47.86 billion in debt, giving a net cash position of -41.02 billion.

Cash & Cash Equivalents	6.84B
Total Debt	47.86B
Net Cash	-41.02B
Net Cash Per Share	n/a
Equity (Book Value)	6.32B
Book Value Per Share	11.75
Working Capital	5.33B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 10.23 billion and capital expenditures -1.20 billion, giving a free cash flow of 9.03 billion.

Operating Cash Flow	10.23B
Capital Expenditures	-1.20B
Free Cash Flow	9.03B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 69.36%, with operating and profit margins of 30.75% and 18.96%.

Gross Margin	69.36%
Operating Margin	30.75%
Pretax Margin	21.26%
Profit Margin	18.96%
EBITDA Margin	46.25%
EBIT Margin	30.75%
FCF Margin	30.37%

Dividends & Yields

This stock pays an annual dividend of 8.59, which amounts to a dividend yield of 3.43%.

Dividend Per Share	8.59
Dividend Yield	3.43%
Dividend Growth (YoY)	6.27%
Years of Dividend Growth	14
Payout Ratio	82.46%
Buyback Yield	-0.19%
Shareholder Yield	3.25%
Earnings Yield	4.20%
FCF Yield	6.73%

Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Amgen has an Altman Z-Score of 1.68 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.68
Piotroski F-Score	7